Alumis Inc. (ALMS) Stock Grade

About Alumis Inc.'s fundamentals

Alumis Inc. is a biotechnology company with a market capitalization of $8.3 billion that reported zero revenue growth year-over-year, indicating flat sales performance. The company posted a significant net loss in its latest annual statement, reflected in a net margin of -1011.8%, meaning operating expenses far exceeded any revenue generated. The company does not pay a dividend and lacks calculable profitability metrics such as a P/E ratio and return on equity, which is typical for pre-revenue or early-stage biotech firms focused on research and development.